AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32353623 — intervention group
Group type: COMPARATOR
Intervention: Labral size
Number of subjects: 571
Study 35940872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose gel (40% dextrose)
Number of subjects: 185
Study 35940872 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 185
Study 33642566 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (338 patients)
Number of subjects: 694
Study 33642566 — intervention group
Group type: COMPARATOR
Intervention: Control group (356 patients)
Number of subjects: 694
Study 32224029 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical linear incision (n=20)
Number of subjects: 40
Study 32224029 — intervention group
Group type: COMPARATOR
Intervention: Modified Dandy incision (n=20)
Number of subjects: 40
Study 35866509 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid-femoral pulse-wave velocity (cfPWV)
Number of subjects: 18
Study 35866509 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial-femoral pulse-wave velocity (bfPWV)
Number of subjects: 18
Study 34052785 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth technology-centered intervention using a Vaica electronic pill tray and blue-toothed UA-767Plus BT blood pressure device with a dedicated app for data relay.
Number of subjects: 200
Study 34052785 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth technology-centered intervention
Number of subjects: 200
Study 36478707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (2 μg) with 10 mg intrathecal bupivacaine
Number of subjects: 105
Study 36478707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (10 μg) with 10 mg intrathecal bupivacaine
Number of subjects: 105
Study 36478707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cocktail of 1 g acetaminophen, 5 mg morphine, and 100 μg fentanyl with 10 mg intrathecal bupivacaine
Number of subjects: 105
Study 33181549 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantation of autologous adipose‐derived adult stem cells
Number of subjects: 14
Study 33181549 — intervention group
Group type: EXPERIMENTAL
Intervention: Decellularized donor corneal stroma laminas
Number of subjects: 14
Study 33181549 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantation of recellularized donor laminas with adipose‐derived adult stem cells
Number of subjects: 14
Study 33181549 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic SMILE implantation lenticule corneal inlays
Number of subjects: 14
Study 34474038 — intervention group
Group type: EXPERIMENTAL
Intervention: PTG-100 (150, 300, or 900 mg)
Number of subjects: 100
Study 34474038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33177476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LDMTX) 10 mg
Number of subjects: 176
Study 33177476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 33047449 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise associated with abdominal laser therapy (LLLT) for 50 minutes at 45%-55% of reserve heart rate
Number of subjects: 36
Study 33047449 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise only (without LLLT)
Number of subjects: 36
Study 33047449 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (only LLLT without power)
Number of subjects: 36
Study 33047449 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups (EG1 and EG2)
Number of subjects: 36
Study 32395870 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching-Adjusted Indirect Comparison (MAIC) using Method of Moments
Number of subjects: 0
Study 32395870 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching-Adjusted Indirect Comparison (MAIC) using Entropy Balancing
Number of subjects: 0
Study 32395870 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard MAIC (based on Method of Moments)
Number of subjects: 0
Study 35668346 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid alone
Number of subjects: 52
Study 35668346 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid coadministered with Bedaquiline
Number of subjects: 52
Study 35668346 — intervention group
Group type: EXPERIMENTAL
Intervention: DM-6705 metabolite
Number of subjects: 52
Study 35668346 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of plasma albumin concentrations
Number of subjects: 52
Study 35668346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients’ demographics (including HIV)
Number of subjects: 52
Study 33526499 — intervention group
Group type: EXPERIMENTAL
Intervention: Link worker intervention over a 1-month period
Number of subjects: 600
Study 33526499 — intervention group
Group type: COMPARATOR
Intervention: Wait list control receiving usual GP care
Number of subjects: 600
Study 35332237 — intervention group
Group type: EXPERIMENTAL
Intervention: Head positioning intervention (supine position, head position changed every 2 hours to one of six randomized modes)
Number of subjects: 39
Study 32139216 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct TAVR without prior balloon valvuloplasty (n=97)
Number of subjects: 236
Study 32139216 — intervention group
Group type: COMPARATOR
Intervention: TAVR with prior balloon valvuloplasty (BAV) (n=87)
Number of subjects: 236
Study 32139216 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct TAVR without prior BAV
Number of subjects: 236
Study 32139216 — intervention group
Group type: COMPARATOR
Intervention: BAV group
Number of subjects: 236
Study 32139216 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct implantation group
Number of subjects: 236
Study 32139216 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 236
Study 37434189 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic manipulation
Number of subjects: 199
Study 37434189 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 199
Study 33762197 — intervention group
Group type: EXPERIMENTAL
Intervention: USG transmuscular quadratus lumborum block (QLB)
Number of subjects: 48
Study 33762197 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral USG posterior transversus abdominis plane (TAP) block
Number of subjects: 48
Study 33762197 — intervention group
Group type: COMPARATOR
Intervention: Control group (no blocks)
Number of subjects: 48
Study 33086652 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels <30 nmol/L in the first trimester
Number of subjects: 422
Study 33086652 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels <20 nmol/L in the first trimester
Number of subjects: 422
Study 33086652 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels <30 nmol/L in the third trimester
Number of subjects: 422
Study 34366293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bhramari pranayama (Bhr. P) for 45 min, thrice a week for six months
Number of subjects: 26
Study 34366293 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study 34922436 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab
Number of subjects: 837
Study 34922436 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab
Number of subjects: 837
Study 34922436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 837
Study 35669488 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX Good Behaviour Game implementation intervention
Number of subjects: 40
Study 35669488 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX Good Behaviour Game
Number of subjects: 40
Study 32666123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lusutrombopag 0.75 mg for 6 days (first dose: 1.5 mg)
Number of subjects: 31
Study 32666123 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 400-600 mg
Number of subjects: 31
Study 35342620 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Remote Ischemic Conditioning (RIC)
Number of subjects: 16
Study 35342620 — intervention group
Group type: COMPARATOR
Intervention: Sham Remote Ischemic Conditioning (RIC)
Number of subjects: 16
Study 32969169 — intervention group
Group type: EXPERIMENTAL
Intervention: Adj‐BFA (Battlefield acupuncture)
Number of subjects: 90
Study 32969169 — intervention group
Group type: COMPARATOR
Intervention: Adj‐Sham (sham acupuncture)
Number of subjects: 90
Study 32969169 — intervention group
Group type: COMPARATOR
Intervention: SAC (standard analgesia care)
Number of subjects: 90
Study 32969169 — intervention group
Group type: EXPERIMENTAL
Intervention: Adj‐BFA, Adj‐Sham, SAC
Number of subjects: 90
Study 35562030 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine examination (video-guided)
Number of subjects: 32
Study 35562030 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine maneuvers examining ROM limitations
Number of subjects: 32
Study 35562030 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine maneuvers identifying apprehension associated with glenohumeral instability
Number of subjects: 32
Study 35562030 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine experience
Number of subjects: 32
Study 33207285 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion induction condition (sadness only)
Number of subjects: 117
Study 33207285 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion induction condition (anger only)
Number of subjects: 117
Study 33207285 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion induction condition (sadness and anger)
Number of subjects: 117
Study 33207285 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination induction
Number of subjects: 117
Study 33207285 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 117
Study 32497779 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic 2000
Number of subjects: 182
Study 35086230 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon-cut DSAEK
Number of subjects: 0
Study 35086230 — intervention group
Group type: COMPARATOR
Intervention: Pre-cut DSAEK
Number of subjects: 0
Study 35086230 — intervention group
Group type: COMPARATOR
Intervention: Pre-loaded DSAEK
Number of subjects: 0
Study 34055723 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Norms feedback intervention
Number of subjects: 4463
Study 34055723 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 4463
Study 32562877 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab 3.0 mg/kg every 4 weeks for 1 year
Number of subjects: 953
Study 32562877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 953
Study 36045765 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect-composite-resin (ICR) crowns
Number of subjects: 20
Study 36045765 — intervention group
Group type: COMPARATOR
Intervention: Porcelain-fused-to-metal (PFM) crowns
Number of subjects: 20
Study 36045765 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall implant survival
Number of subjects: 20
Study 33524367 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02%
Number of subjects: 20
Study 33524367 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study 35211980 — intervention group
Group type: EXPERIMENTAL
Intervention: PRBC transfusion volume based on patient's weight (Group A)
Number of subjects: 60
Study 35211980 — intervention group
Group type: COMPARATOR
Intervention: PRBC volume calculated using a formula (Group B)
Number of subjects: 60
Study 35933379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacrystim® treatment (3 IPL sessions at D0, D15, and D45 with 4 shots per side at a fluence of 8 mJ/cm2)
Number of subjects: 45
Study 35933379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacrystim® treatment
Number of subjects: 45
Study 32172362 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Physical Activity Intervention (MPAI) for 6 months
Number of subjects: 40
Study 32172362 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 616599967 — intervention group
Group type: EXPERIMENTAL
Intervention: JASPER parent‐mediated intervention
Number of subjects: 86
Study 616599967 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational intervention
Number of subjects: 86
Study 616599967 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirrored pacing strategy
Number of subjects: 86
Study 34705783 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-segment surgically assisted rapid maxillary expansion
Number of subjects: 32
Study 34705783 — intervention group
Group type: COMPARATOR
Intervention: Two-segment surgically assisted rapid maxillary expansion
Number of subjects: 32
Study 32617609 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ACL and ALL reconstruction (group B)
Number of subjects: 107
Study 32617609 — intervention group
Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (ACLR) (group A)
Number of subjects: 107
Study 35196668 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (chemotherapy and radiation therapy)
Number of subjects: 109
Study 35196668 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 109
Study 33235112 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition combined with accelerated rehabilitation
Number of subjects: 100
Study 33235112 — intervention group
Group type: COMPARATOR
Intervention: Routine nutrition (Control)
Number of subjects: 100
Study 32482570 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty combined with turbinoplasty
Number of subjects: 137
Study 32482570 — intervention group
Group type: COMPARATOR
Intervention: Septoplasty alone
Number of subjects: 137
Study 36064436 — intervention group
Group type: EXPERIMENTAL
Intervention: BEAM app-based program
Number of subjects: 140
Study 36064436 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 140
Study 33250396 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy program with strengthening (Group 1, n = 38)
Number of subjects: 94
Study 33250396 — intervention group
Group type: COMPARATOR
Intervention: Therapy program without strengthening (Group 2, n = 21)
Number of subjects: 94
Study 33524052 — intervention group
Group type: EXPERIMENTAL
Intervention: Brucella antibodies by IgG ELISA
Number of subjects: 4746
Study 33524052 — intervention group
Group type: EXPERIMENTAL
Intervention: Brucella antibodies by IgM ELISA
Number of subjects: 4746
Study 33524052 — intervention group
Group type: EXPERIMENTAL
Intervention: Brucella antibodies by RBT
Number of subjects: 4746
Study 33524052 — intervention group
Group type: EXPERIMENTAL
Intervention: TaqMan Array Card (TAC) testing
Number of subjects: 4746
Study 33524052 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed brucellosis cases
Number of subjects: 4746
Study 33208303 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) treatment
Number of subjects: 74
Study 33208303 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HFNC)
Number of subjects: 74
Study 35999942 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat pulmonary rehabilitation program
Number of subjects: 907
Study 35999942 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat pulmonary rehabilitation program (twice in 12 months)
Number of subjects: 907
Study 34654584 — intervention group
Group type: EXPERIMENTAL
Intervention: High VRSA dosage (H-VRSA)
Number of subjects: 0
Study 34654584 — intervention group
Group type: COMPARATOR
Intervention: Low VRSA dosage (L-VRSA)
Number of subjects: 0
Study 34654584 — intervention group
Group type: COMPARATOR
Intervention: Services as Usual (SAU)
Number of subjects: 0
Study 34705756 — intervention group
Group type: COMPARATOR
Intervention: IV TXA alone (group IV, n = 48)
Number of subjects: 141
Study 34705756 — intervention group
Group type: EXPERIMENTAL
Intervention: IV TXA followed by oral TXA for 2 days (group 2D, n = 46)
Number of subjects: 141
Study 34705756 — intervention group
Group type: EXPERIMENTAL
Intervention: IV TXA followed by oral TXA for 5 days (group 5D, n = 47)
Number of subjects: 141
Study 32331034 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin (PIM) 34 mg/day
Number of subjects: 203
Study 32331034 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 203
Study 35364638 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (LF-rTMS)
Number of subjects: 60
Study 35364638 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (HF-rTMS)
Number of subjects: 60
Study 35364638 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 60
Study 32910030 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional picosecond 1064-nm laser (FxPico)
Number of subjects: 25
Study 32910030 — intervention group
Group type: COMPARATOR
Intervention: Fractional carbon dioxide laser (FxCO2)
Number of subjects: 25
Study 36418455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking with integrated resistance shock absorber (RSA)
Number of subjects: 25
Study 36418455 — intervention group
Group type: COMPARATOR
Intervention: Nordic walking with classic poles (NW)
Number of subjects: 25
Study 32386721 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 268
Study 32386721 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 268
Study 32386721 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 268
Study 33109476 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic Touch sirolimus coated-balloon (SCB)
Number of subjects: 114
Study 33109476 — intervention group
Group type: COMPARATOR
Intervention: SeQuent Please Neo paclitaxel coated balloon (PCB)
Number of subjects: 114
Study 36114080 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based Training
Number of subjects: 0
Study 36114080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33122892 — intervention group
Group type: EXPERIMENTAL
Intervention: Evogliptin 5 mg once daily for 7 days (EVO)
Number of subjects: 34
Study 33122892 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of evogliptin 5 mg and pioglitazone 30 mg once daily for 7 days (EVO+PIO)
Number of subjects: 34
Study 33122892 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 30 mg once daily for 7 days (PIO)
Number of subjects: 34
Study 33122892 — intervention group
Group type: EXPERIMENTAL
Intervention: EVO+PIO
Number of subjects: 34
Study 34229571 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 4
Study 34229571 — intervention group
Group type: EXPERIMENTAL
Intervention: Random
Number of subjects: 4
Study 34229571 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort
Number of subjects: 4
Study 34229571 — intervention group
Group type: EXPERIMENTAL
Intervention: NO
Number of subjects: 4
Study 34516312 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of intravenous Solumedrol every 8 hours for 7 days
Number of subjects: 43
Study 34516312 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo every 8 hours for 7 days
Number of subjects: 43
Study 33932648 — intervention group
Group type: EXPERIMENTAL
Intervention: Concealing the hydration fluid bottle during hydration
Number of subjects: 62
Study 33932648 — intervention group
Group type: COMPARATOR
Intervention: Routine procedure (No concealment intervention) during hydration
Number of subjects: 62
Study 35657079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib (560 mg, orally once daily) plus bendamustine (90 mg/m²) and rituximab (375 mg/m²)
Number of subjects: 523
Study 35657079 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus bendamustine (90 mg/m²) and rituximab (375 mg/m²)
Number of subjects: 523
Study 34023288 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 82
Study 34023288 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative intervention
Number of subjects: 82
Study 32023423 — intervention group
Group type: EXPERIMENTAL
Intervention: MPR technique
Number of subjects: 48
Study 32023423 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS technique
Number of subjects: 48
Study 32023423 — intervention group
Group type: EXPERIMENTAL
Intervention: INIT technique
Number of subjects: 48
Study 32456475 — intervention group
Group type: EXPERIMENTAL
Intervention: coached feigning of ADHD
Number of subjects: 75
Study 32456475 — intervention group
Group type: EXPERIMENTAL
Intervention: coached feigning of depression and anxiety (DA)
Number of subjects: 75
Study 32456475 — intervention group
Group type: COMPARATOR
Intervention: honest responding (HR)
Number of subjects: 75
Study 33839205 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 548
Study 33839205 — intervention group
Group type: EXPERIMENTAL
Intervention: NTCP model for predicting ANCSA
Number of subjects: 548
Study 33839205 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration test for NTCP model
Number of subjects: 548
Study 35675356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implants with additional visual cues
Number of subjects: 16
Study 35675356 — intervention group
Group type: COMPARATOR
Intervention: Cochlear implants alone
Number of subjects: 16
Study 35675356 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids in the contralateral ear
Number of subjects: 16
Study 35675356 — intervention group
Group type: COMPARATOR
Intervention: Audio-only condition
Number of subjects: 16
Study 35675356 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual condition
Number of subjects: 16
Study 34265407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox 30 mg tablet formulations (slow, medium, fast dissolution)
Number of subjects: 60
Study 34265407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox 30 mg with high-fat/high-calorie meal
Number of subjects: 60
Study 34265407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox 30 mg with low-fat meal
Number of subjects: 60
Study 34265407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox 30 mg with dairy-based meal
Number of subjects: 60
Study 34852767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride (1.5 mg/kg induction and 2 mg/kg/h maintenance)
Number of subjects: 40
Study 34852767 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 40
Study 34971713 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Cognitive protocol
Number of subjects: 200
Study 34971713 — intervention group
Group type: COMPARATOR
Intervention: Control protocol
Number of subjects: 200